Institut de Recerca Biomèdica de Lleida (IRBLleida)
Research facility
Location:
Lleida,
Spain (ES)
ISNI: 000000040425020X
ROR: https://ror.org/03mfyme49
Development and validation of a high-throughput screening pipeline of compound libraries to target EMT (2025)
Jonckheere S, Taminau J, Adams J, Haerinck J, De Coninck J, Verstappe J, De Clercq K, et al.
Journal article
A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens (2023)
Almenara-Fuentes L, Rodriguez-Fernandez S, Rosell-Mases E, Kachler K, You A, Salvado M, Andreev D, et al.
Journal article
Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study (2023)
Mark PB, Carrero JJ, Matsushita K, Sang Y, Ballew SH, Grams ME, Coresh J, et al.
Journal article
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease (2021)
Ortiz A, Ferro CJ, Balafa O, Burnier M, Ekart R, Halimi JM, Kreutz R, et al.
Journal article
Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets (2020)
Matsushita K, Jassal SK, Sang Y, Ballew SH, Grams ME, Surapaneni A, Arnlov J, et al.
Journal article